Deleted No
Hibernated Yes
Last Checked July 29, 2021

Created

Fri Jun 11 11:10:00 +0000 2021

Likes

12

Retweets

8

Source

TweetDeck

View Raw Data

JSON Data

View on Twitter

Likely Available
Profile Image

Axios @axios

In an interview with Axios, two Biogen executives insisted the company's unproven $55,000 Alzheimer's drug is priced fairly, and that it didn't conduct another clinical trial before approval because the FDA didn't push them to do so. https://t.co/nuKvFJiv1A — PolitiTweet.org

Posted June 11, 2021 Hibernated